NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
6.90
-0.10 (-1.43%)
Mar 27, 2026, 4:00 PM EDT - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $77.19 million as of March 27, 2026. Its market cap has increased by 412.23% in one year.
Market Cap
77.19M
Enterprise Value
72.66M
1-Year Change
412.23%
Ranking
Category
Stock Price
$6.90
Market Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $77.19M, an increase of 320.18%. That is a compound annual growth rate of 72.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 77.19M | 59.61% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Champions Oncology | 80.40M |
| Kazia Therapeutics | 79.92M |
| NRx Pharmaceuticals | 78.70M |
| PolyPid | 78.64M |
| aTyr Pharma | 77.73M |
| Aardvark Therapeutics | 76.57M |
| Pelthos Therapeutics | 76.31M |
| Pliant Therapeutics | 76.16M |